Author

Paige Witucki

Institution: University of Iowa

Observed institutions: Eugene Applebaum College of Pharmacy and Health Sciences, University of Iowa, Wayne State University

OpenAlex ID: A5001892878

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022

2023 · Ashlan J. Kunz Coyne, Sara Alosaimy, et al. · Microbiology Spectrum · 37

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

2023 · Nicholas Rebold, Abdalhamid M. Lagnf, et al. · Microbiology Spectrum · 24

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

2023 · Ashlan J Kunz Coyne, Amer El Ghali, et al. · Open Forum Infectious Diseases · 23

Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam

2022 · Sara Alosaimy, Abdalhamid M Lagnf, et al. · Clinical Infectious Diseases · 15

Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes

2025 · Ashlan J. Kunz Coyne, Sara Alosaimy, et al. · Microbiology Spectrum · 9

A double-blinded, placebo-controlled field trial of an OspA-based oral reservoir targeted vaccine against Borrelia burgdorferi

2026 · Amy M. Schwartz, Ferney Henao-Ceballos, et al. · npj Vaccines · 2

1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections

2022 · Amer El Ghali, Amer El Ghali, et al. · Open Forum Infectious Diseases · 1

2779. Early Administration of Ceftazidime-Avibactam for Carbapenem-Resistant Enterobacterales Is Associated with Improved Clinical Success

2023 · Ashlan J Kunz Coyne, Kristen Lucas, et al. · Open Forum Infectious Diseases

Works count: 8

Citation count: 111

H-index: 5

I10-index: 4